BioSpace News Archive

Stallergenes Greer, a biopharmaceutical company specialising in treatments for respiratory allergies, today announced its half-year results for the six-month period ended 30 June 2018.

The Arizona Bioindustry Association (AZBio) today announced that AdviNow Medical has won a 2018 AZBio Fast Lane Award for its rapid progression from concept to exciting product launch.

ArQule, Inc. today announced that Paolo Pucci, Chief Executive Officer, and Marc Schegerin, Senior Vice President, Strategy, Communication and Finance, will present at the 20th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC, on September 5, 2018, at 12:05pm ET at the St. Regis New York Hotel in New York City.

Veracyte, Inc. (Nasdaq: VCYT) today announced that the company has named Angeline (“Angie”) McCabe as vice president, investor relations and corporate communications, effective immediately

erastem, Inc.. (Nasdaq: VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced the appointment of Robert E. Gagnon, an experienced financial executive, as Chief Financial Officer, effective August 28, 2018.

Perrigo Company plc (NYSE; TASE: PRGO) today announced that it has postponed its investor event to discuss its long-term consumer growth strategies and key operational initiatives, previously planned as a conference call for September 25, 2018.

TSO3 Inc. announced today that it has appointed Mr. Martin J. Madden to the Company’s board of directors.

Morphogenesis, Inc., a Tampa, FL-based immunotherapy company celebrates the launch of its first human clinical study in a strategic collaboration with the Cutaneous Oncology Program at Moffitt Cancer Center.

AOFAS® members travel to Vietnam for 17th consecutive year

Mirati Therapeutics, Inc. will participate in two panel discussions, at the 2018 Citi Biotech Conference in Boston. Charles M. Baum, M.D., Ph.D., President and Chief Executive Officer will represent Mirati at the event.